QI Path Launches AI-driven Risk Intelligence Platform To Transform Risk Mitigation and Regulatory Readiness Across the Drug Development Lifecycle
In response to the mounting regulatory, operational, and reputational pressures facing pharmaceutical companies and clinical research organizations (CROs), QI Path announced today the official launch of its AI-driven, purpose-built risk governance platform for the life sciences industry. Designed to transform how companies anticipate, mitigate, and manage operational risk proactively, QI Path delivers structured, real-time visibility […]